Five years of self-administered hyaluronidase facilitated subcutaneous immunoglobulin (fSCIg) home therapy in a patient with primary immunodeficiency

J Clin Pathol. 2016 Jan;69(1):87-8. doi: 10.1136/jclinpath-2015-202901. Epub 2015 Jul 17.
No abstract available

Keywords: IMMUNODEFICIENCY; IMMUNOGLOBULIN; IMMUNOLOGY.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Drug Administration Schedule
  • Female
  • Humans
  • Hyaluronoglucosaminidase / administration & dosage*
  • Immunoglobulins / administration & dosage*
  • Infusions, Subcutaneous
  • Self Administration
  • Severe Combined Immunodeficiency / diagnosis
  • Severe Combined Immunodeficiency / drug therapy*
  • Severe Combined Immunodeficiency / immunology
  • Thigh
  • Time Factors
  • Treatment Outcome

Substances

  • Immunoglobulins
  • Hyaluronoglucosaminidase